Exalenz Lab Mode System Compared to Biopsy for H.Pylori Detection

Clinical trial NCT02528721 · COMPLETED

Trial details

NCT number: NCT02528721
Sponsor: Meridian Bioscience, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Helicobacter Pylori Infection

Start date: 2015-10-01
Primary completion: 2016-06-01
Enrollment: 282

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.